Whole-exome sequencing for relapse prediction in patients discontinuing TKI treatment in chronic myeloid leukemia

Leuk Lymphoma. 2016 Jul;57(7):1503-4. doi: 10.3109/10428194.2016.1151514. Epub 2016 Feb 25.

Authors

Sameem Abedin¹, Leonidas C Platanias^{1

2}

Affiliations

¹ a Robert H. Lurie Comprehensive Cancer Center and Division of Hematology-Oncology , Feinberg School of Medicine, Northwestern University , Chicago , IL , USA ;
² b Department of Medicine , Jesse Brown Veterans Affairs Medical Center , Chicago , IL , USA.

PMID: 26915266
DOI: 10.3109/10428194.2016.1151514

No abstract available

Publication types

Comment

MeSH terms

Chronic Disease
Exome*
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
Recurrence